- Home
- SNGX vs VAPE Comparison
SNGX vs VAPE Comparison
Compare SNGX & VAPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- VAPE
- Stock Information
- Founded
- SNGX 1987
- VAPE N/A
- Country
- SNGX United States
- VAPE United States
- Employees
- SNGX N/A
- VAPE N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- VAPE
- Sector
- SNGX Health Care
- VAPE
- Exchange
- SNGX Nasdaq
- VAPE NYSE
- Market Cap
- SNGX 6.5M
- VAPE 6.0M
- IPO Year
- SNGX 1987
- VAPE N/A
- Fundamental
- Price
- SNGX $1.36
- VAPE $9.08
- Analyst Decision
- SNGX Strong Buy
- VAPE
- Analyst Count
- SNGX 1
- VAPE 0
- Target Price
- SNGX $6.00
- VAPE N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- VAPE 6.4K
- Earning Date
- SNGX 08-08-2025
- VAPE 08-13-2025
- Dividend Yield
- SNGX N/A
- VAPE N/A
- EPS Growth
- SNGX N/A
- VAPE N/A
- EPS
- SNGX N/A
- VAPE N/A
- Revenue
- SNGX $2,342.00
- VAPE $3,282,424.00
- Revenue This Year
- SNGX N/A
- VAPE N/A
- Revenue Next Year
- SNGX N/A
- VAPE N/A
- P/E Ratio
- SNGX N/A
- VAPE N/A
- Revenue Growth
- SNGX N/A
- VAPE 33.28
- 52 Week Low
- SNGX $1.09
- VAPE $5.60
- 52 Week High
- SNGX $7.20
- VAPE $12.26
- Technical
- Relative Strength Index (RSI)
- SNGX 44.21
- VAPE N/A
- Support Level
- SNGX $1.24
- VAPE N/A
- Resistance Level
- SNGX $1.40
- VAPE N/A
- Average True Range (ATR)
- SNGX 0.14
- VAPE 0.00
- MACD
- SNGX 0.03
- VAPE 0.00
- Stochastic Oscillator
- SNGX 34.18
- VAPE 0.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About VAPE CEA INDUSTRIES INC
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.